Henry Schein, Inc. vs Lana Medical Co.
A head-to-head of Henry Schein, Inc. (HSIC) and Lana Medical Co. (9587) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | HSIC | 9587 |
|---|---|---|
| Market Cap | $10.00B | 149.04M SAR |
| P/E (TTM) | 25.44 | 52.47 |
| Forward P/E | 12.31 | — |
| P/S | 0.63 | 1.61 |
| P/B | 2.08 | 2.17 |
| EV/EBITDA | 12.80 | 16.90 |
| Dividend Yield | — | — |
| Profit Margin | 2.95% | 2.92% |
| Gross Margin | 31.14% | 22.58% |
| Operating Margin | 5.75% | 7.45% |
| Revenue Growth (YoY) | +6.31% | -11.60% |
| FCF Yield | 4.74% | — |
| Debt / Equity | 70.68 | 31.02 |
| Current Ratio | 1.36 | 1.58 |
Which is better: Henry Schein, Inc. or Lana Medical Co.?
- ✓Larger by market cap: Henry Schein, Inc.
- ✓Cheaper valuation (lower P/E): Henry Schein, Inc.
- ✓More profitable (net margin): Henry Schein, Inc.
- ✓Faster revenue growth: Henry Schein, Inc.
Across 10 available metrics, Henry Schein, Inc. leads 7–3.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
Compare Henry Schein, Inc. with others
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.